David Ricks
David Ricks is the Chief Executive Officer of Eli Lilly and Company, a leading pharmaceutical company known for its innovations in diabetes and weight loss medications, including Zepbound and Mounjaro. Under his leadership, the company announced a significant $27 billion investment to expand its manufacturing capabilities in the United States, aiming to bolster domestic production in response to potential tariffs and supply chain vulnerabilities exposed during the COVID-19 pandemic. Ricks has emphasized the importance of reshoring production and increasing manufacturing capacity to meet the growing demand for Eli Lilly's products.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Andorra:
David Ricks is the CEO of Eli Lilly who was speaking when Gordon Findlay fainted.
5
Romania:
David Ricks was speaking about a drug agreement when Gordon Findlay collapsed.
5
Turkey:
David Ricks was speaking when the incident occurred at the White House.
5
Luxembourg:
David Ricks is the CEO of Eli Lilly who was speaking about a weight loss drug deal when the incident occurred.
5
United Kingdom:
David Ricks, Eli Lilly's chief executive, said in a statement that Lilly is in a unique position to work with the US government to rebalance the global system.
8
Greece:
David Ricks believes that Giannis Skarimpas would appeal to English-speaking audiences who appreciate Beckett's prose.
8
United States:
Eli Lilly, led by David Ricks, is putting $27 billion into expanding domestic pharmaceutical production.
8
Ireland:
David Ricks is Eli Lilly’s chief executive who commented on the potential of the new weight-loss pill.
8
Ireland:
David Ricks, Eli Lilly’s chief executive, stated that orforglipron may provide a new option for weight management.
8
United Kingdom:
David Ricks, Eli Lilly’s chief executive, discussed the potential of orforglipron as a new option for weight management.
8